Related Experiment Video
Updated: Jul 12, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Roles of Smad3 in TGF-beta signaling during carcinogenesis
Caroline Millet1, Ying E Zhang
1Laboratory of Cellular and Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 37, Room 2056B, Bethesda, MD 20892-4256, USA.
Abstract:
Signaling of transforming growth factor beta (TGF-beta) is mediated through a heteromeric complex of two types of transmembrane receptors and downstream intracellular proteins known as Smads. Alterations of TGF-beta signaling underlie various forms of human cancer and developmental diseases. Human genetic studies have revealed both point mutations and deletions of Smad2 or Smad4 in several types of cancers. However, the role of Smad3 in tumorigenesis is not clear. Recent data indicate that Smad3 also functions as a tumor suppressor by inhibiting cell proliferation and promoting apoptosis. In addition, Smad3 is essential for TGF-beta-mediated immune suppression, and it plays an important role in regulating transcriptional responses that are favorable to metastasis. Therefore, through regulating different transcriptional responses, Smad3 functions as both a negative and positive regulator of carcinogenesis depending on cell type and clinical stage of the tumor.
Insights
Transforming growth factor beta (TGF-beta) signaling involves Smad proteins. Smad3 acts as both a tumor suppressor and promoter, influencing cancer development and metastasis.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Signaling
Background:
- Transforming growth factor beta (TGF-beta) signaling is crucial for cellular functions and is mediated by Smad proteins.
- Dysregulation of TGF-beta signaling is implicated in various human cancers and developmental disorders.
- While Smad2 and Smad4 alterations are linked to cancer, the specific role of Smad3 in tumorigenesis remains less understood.
Purpose of the Study:
- To elucidate the multifaceted role of Smad3 in cancer development and progression.
- To investigate Smad3's function as a tumor suppressor and its influence on metastasis.
- To understand how Smad3 regulates transcriptional responses in different cellular contexts.
Main Methods:
- Review of existing human genetic studies on Smad mutations in cancer.
- Analysis of recent data on Smad3's function in cell proliferation and apoptosis.
- Examination of Smad3's role in TGF-beta-mediated immune suppression and metastasis regulation.
Main Results:
- Smad3 exhibits tumor suppressor activities by inhibiting cell proliferation and promoting apoptosis.
- Smad3 is essential for TGF-beta-induced immune suppression.
- Smad3 influences transcriptional responses that can either favor or inhibit metastasis.
Conclusions:
- Smad3 plays a dual role in carcinogenesis, acting as both a negative and positive regulator.
- The specific function of Smad3 depends on the cell type and the clinical stage of the tumor.
- Further research into Smad3's complex regulatory mechanisms is warranted for cancer therapy.
More Related Videos
11:06Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System
Published on: July 30, 2018
11:38Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
Related Concept Videos
TGF - β Signaling Pathway
Hedgehog Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The JAK-STAT Signaling Pathway
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Abnormal Proliferation